Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Soochow UniversityActive in the last 2 years

Yijun Wei

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5083338720. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. Co-author DOI 10.1016/j.gendis.2025.101870↗
  2. Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. Co-author DOI 10.21037/jgo-21-303↗
  3. Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis. Co-author DOI 10.7150/jca.48661↗
  4. DcR3 promotes proliferation and invasion of pancreatic cancer via a DcR3/STAT1/IRF1 feedback loop. Co-author PMID 31911850↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian Zhou · 4 shared papers, 2019–2026 · strength 0.64
  2. Yuchen Tang · 3 shared papers, 2021–2026 · strength 0.55
  3. Haoran Li · 2 shared papers, 2021–2026 · strength 0.42
  4. Bin Yi · 2 shared papers, 2021–2026 · strength 0.42
  5. Jian Yang · 2 shared papers, 2019–2026 · strength 0.39
  6. Jun Yao · 1 shared paper, 2026 · strength 0.29
  7. Dechun Li · 2 shared papers, 2019–2021 · strength 0.22
  8. Jun Yao · 2 shared papers, 2019–2021 · strength 0.22
  9. Dongming Zhu · 1 shared paper, 2021 · strength 0.13
  10. Chen Zhang · 1 shared paper, 2021 · strength 0.13
  11. Zixiang Zhang · 1 shared paper, 2021 · strength 0.13
  12. Zixiang Zhang · 1 shared paper, 2019 · strength 0.10
  13. Dongming Zhu · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.